Your session is about to expire
← Back to Search
Online Safety Intervention for Dementia Caregivers
N/A
Waitlist Available
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Speak English or Spanish
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks, 2 months, 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether an online intervention can reduce firearm injury risk in caregivers of people with dementia.
Who is the study for?
This trial is for informal caregivers in the U.S. who look after someone with dementia at home and have access to a firearm. Participants must speak English or Spanish and have internet access. Caregivers of those in legal custody or institutionalized cannot join.
What is being tested?
'Safety in Dementia' is an online intervention being tested nationally for its effectiveness on caregivers managing dementia patients with firearm access, using randomized assignment and long-term follow-up.
What are the potential side effects?
Since this study involves an online intervention rather than medication, traditional physical side effects are not applicable. However, participants may experience emotional or psychological stress.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can communicate in English or Spanish.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 weeks, 2 months, 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks, 2 months, 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Preparation for Decision Making
Secondary study objectives
Action to reduce firearm access
Caregiver burden
Change in Decision Self-Efficacy
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Safety in DementiaExperimental Treatment1 Intervention
Safety in Dementia is an online tool that, in a stepwise fashion, guides a caregiver individual through decisions related to firearm access for a person with dementia. It includes information and a comparison of the options and their risks and benefits. It guides the caregiver through clarification of personal feelings and values and identifying their decision/plan.
Group II: Web controlActive Control1 Intervention
The control group will view National Institute on Aging Home Safety Checklist.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Safety in Dementia
2022
N/A
~500
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,802 Previous Clinical Trials
2,821,612 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I care for someone with dementia who has access to a firearm.I can communicate in English or Spanish.
Research Study Groups:
This trial has the following groups:- Group 1: Web control
- Group 2: Safety in Dementia
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger